ID: ALA4853429

Max Phase: Preclinical

Molecular Formula: C20H15F4N5O2

Molecular Weight: 433.37

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C[C@](O)(Cn1nncc1-c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1

Standard InChI:  InChI=1S/C20H15F4N5O2/c1-19(31,11-29-17(10-26-28-29)12-2-5-14(21)6-3-12)18(30)27-15-7-4-13(9-25)16(8-15)20(22,23)24/h2-8,10,31H,11H2,1H3,(H,27,30)/t19-/m0/s1

Standard InChI Key:  ANWMMCFSCHWTDE-IBGZPJMESA-N

Associated Targets(Human)

Androgen Receptor 11781 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Androgen Receptor 5522 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 433.37Molecular Weight (Monoisotopic): 433.1162AlogP: 3.36#Rotatable Bonds: 5
Polar Surface Area: 103.83Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.06CX Basic pKa: 0.58CX LogP: 3.33CX LogD: 3.33
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.60Np Likeness Score: -1.65

References

1. He Y, Hwang DJ, Ponnusamy S, Thiyagarajan T, Mohler ML, Narayanan R, Miller DD..  (2021)  Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer.,  64  (15.0): [PMID:34269581] [10.1021/acs.jmedchem.1c00439]

Source